NASDAQ
Acorda Therapeutics, Inc. (ACOR) has a free cash flow growth of -559.21% as of Friday, May 29, 2026. This represents a 919.22% decrease compared to its 12-month average of -54.87%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.